In thyroid cancers, Thyroid-stimulating Hormone (TSH) is more involved in overcoming senescence; while BRAF overexpression suppresses thyroid hormone biosynthesis and leads to elevated TSH levels in vivo14; it was shown that TSH signaling inhibits BRAFV600E-induced senescence through DUSP623. This evidence concerns the gene BRAF and thyroid gland carcinoma.